BGLC
BioNexus Gene Lab·NASDAQ
--
--(--)
--
--(--)
BGLC Filings
Filing Date
Form Description
Form Type
2026-03-31
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
2026-03-31 ·
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
2026-03-17
Form 8-K - Current report
Key Events
2026-03-17 · Key Events
Form 8-K - Current report
2026-02-23
Form 8-K - Current report
Key Events
2026-02-23 · Key Events
Form 8-K - Current report
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2025-12-30
Form 8-K - Current report
Key Events
2025-12-30 · Key Events
Form 8-K - Current report
2025-12-23
Form 8-K - Current report
Key Events
2025-12-23 · Key Events
Form 8-K - Current report
2025-12-03
Form DEF 14A - Other definitive proxy statements
Key Events
2025-12-03 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-12-02
Form 8-K - Current report
Key Events
2025-12-02 · Key Events
Form 8-K - Current report
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-11-14 · Key Events
Form PRE 14A - Other preliminary proxy statements
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
